BR0215306A - Uso de deoxipeganina - Google Patents

Uso de deoxipeganina

Info

Publication number
BR0215306A
BR0215306A BR0215306-8A BR0215306A BR0215306A BR 0215306 A BR0215306 A BR 0215306A BR 0215306 A BR0215306 A BR 0215306A BR 0215306 A BR0215306 A BR 0215306A
Authority
BR
Brazil
Prior art keywords
deoxipeganine
abuse
depression
deoxipeganin
deoxypeganine
Prior art date
Application number
BR0215306-8A
Other languages
English (en)
Inventor
Joachim Moormann
Hermann Mucke
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of BR0215306A publication Critical patent/BR0215306A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms

Abstract

"USO DE DEOXIPEGANINA". A presente invenção refere-se ao uso de deoxipeganina, como uma base livre ou como um sal ácido de adição, para a produção de drogas que são direcionadas para a terapia de depressão clínica, especialmente de depressão que tem conexão com demência ou com o abuso de álcool e/ou o abuso de nicotina.
BR0215306-8A 2001-12-21 2002-12-14 Uso de deoxipeganina BR0215306A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10163667A DE10163667B4 (de) 2001-12-21 2001-12-21 Verwendung von Desoxypeganin zur Behandlung der klinischen Depression
PCT/EP2002/014274 WO2003053445A1 (de) 2001-12-21 2002-12-14 Verwendung von desoxypeganin zur behandlung der klinischen depression

Publications (1)

Publication Number Publication Date
BR0215306A true BR0215306A (pt) 2004-12-21

Family

ID=7710660

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0215306-8A BR0215306A (pt) 2001-12-21 2002-12-14 Uso de deoxipeganina

Country Status (30)

Country Link
US (1) US20050009813A1 (pt)
EP (1) EP1461042B1 (pt)
JP (1) JP2005513105A (pt)
KR (1) KR100614504B1 (pt)
CN (1) CN1283253C (pt)
AR (1) AR037967A1 (pt)
AT (1) ATE404203T1 (pt)
AU (1) AU2002363874B2 (pt)
BR (1) BR0215306A (pt)
CA (1) CA2471338C (pt)
CZ (1) CZ301210B6 (pt)
DE (2) DE10163667B4 (pt)
DK (1) DK1461042T3 (pt)
EA (1) EA006896B1 (pt)
ES (1) ES2312657T3 (pt)
HK (1) HK1066742A1 (pt)
HU (1) HUP0402298A3 (pt)
IL (2) IL162509A0 (pt)
MX (1) MXPA04006125A (pt)
MY (1) MY138088A (pt)
NO (1) NO326446B1 (pt)
NZ (1) NZ533249A (pt)
PL (1) PL370315A1 (pt)
PT (1) PT1461042E (pt)
SI (1) SI1461042T1 (pt)
SK (1) SK287152B6 (pt)
TW (1) TWI241189B (pt)
UA (1) UA76254C2 (pt)
WO (1) WO2003053445A1 (pt)
ZA (1) ZA200404053B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
WO2004056363A2 (en) 2002-12-20 2004-07-08 Niconovum Ab A physically and chemically stable nicotine-containing particulate material
DE10354893B4 (de) * 2003-11-24 2011-03-10 Hf Arzneimittelforschung Gmbh Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen
DE10354894A1 (de) * 2003-11-24 2005-07-07 Hf Arzneimittelforschung Gmbh Orale Formulierungen des Desoxypeganins und deren Anwendungen
FR2865650B1 (fr) * 2004-01-30 2008-06-13 Biocortech Utilisation du 14,15 dihydro 20,21-dinoreburnamenin14-ol pour traiter et/ou prevenir les depressions majeures et les desordres du cycle veille-sommeil
JP5000932B2 (ja) * 2005-06-21 2012-08-15 日東電工株式会社 ニコチン含有経皮吸収製剤
CA2646942C (en) 2006-03-16 2014-07-29 Niconovum Ab Improved snuff composition
CN101433565B (zh) * 2008-11-26 2013-06-05 上海中医药大学 骆驼蓬属种子总生物碱提取物和它们的制备

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19906979B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit
DE19906977C1 (de) * 1999-02-19 2000-06-15 Lohmann Therapie Syst Lts Desoxypeganin-TTS und seine Verwendung
DE19906975B4 (de) * 1999-02-19 2004-04-15 Lts Lohmann Therapie-Systeme Ag Arzneiform zur Behandlung von Alzheimer'scher Demenz
DE19906978B4 (de) * 1999-02-19 2004-07-08 Lts Lohmann Therapie-Systeme Ag Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus

Also Published As

Publication number Publication date
NO20042476L (no) 2004-06-14
IL162509A (en) 2010-06-16
SI1461042T1 (sl) 2009-02-28
DK1461042T3 (da) 2008-12-01
CA2471338A1 (en) 2003-07-03
WO2003053445A1 (de) 2003-07-03
JP2005513105A (ja) 2005-05-12
NO326446B1 (no) 2008-12-08
MXPA04006125A (es) 2005-05-16
KR100614504B1 (ko) 2006-08-22
ES2312657T3 (es) 2009-03-01
ZA200404053B (en) 2004-10-12
HUP0402298A2 (hu) 2005-02-28
DE10163667B4 (de) 2006-10-26
CN1283253C (zh) 2006-11-08
NZ533249A (en) 2007-05-31
ATE404203T1 (de) 2008-08-15
AU2002363874B2 (en) 2007-12-13
CA2471338C (en) 2009-02-24
EA200400751A1 (ru) 2004-12-30
US20050009813A1 (en) 2005-01-13
WO2003053445A8 (de) 2004-07-01
TWI241189B (en) 2005-10-11
TW200301124A (en) 2003-07-01
EA006896B1 (ru) 2006-04-28
PL370315A1 (en) 2005-05-16
MY138088A (en) 2009-04-30
PT1461042E (pt) 2008-11-03
HUP0402298A3 (en) 2011-03-28
EP1461042B1 (de) 2008-08-13
CN1604781A (zh) 2005-04-06
IL162509A0 (en) 2005-11-20
CZ301210B6 (cs) 2009-12-09
DE50212649D1 (de) 2008-09-25
SK287152B6 (sk) 2010-01-07
DE10163667A1 (de) 2003-07-10
AU2002363874A1 (en) 2003-07-09
HK1066742A1 (en) 2005-04-01
UA76254C2 (en) 2006-07-17
KR20040068327A (ko) 2004-07-30
SK2582004A3 (en) 2004-12-01
CZ2004739A3 (cs) 2004-12-15
AR037967A1 (es) 2004-12-22
EP1461042A1 (de) 2004-09-29

Similar Documents

Publication Publication Date Title
BR0312464A (pt) Inibidores de tirosina quinases
BR0316350A (pt) Diaminotriazóis úteis como inibidores de proteìna cinases
SE0001899D0 (sv) New compounds
BRPI0515592A (pt) medicamentos compreendendo compostos de carbonila, e o uso dos mesmos
BR0208338A (pt) Derivados de piridina
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
BR0212455A (pt) Composto, formulação farmacêutica, combinação, uso de um composto, método para a profilaxia ou tratamento de uma condição clìnica em um mamìfero, e, processo para preparar um composto
BR0016935A (pt) Uso de derivados de ácido fumárico para tratamento de doenças mitocondriais
RS41104A (en) Sulphonamide derivatives, the preparation thereof and the application of same as medicaments
BRPI0208468B8 (pt) camsilato de amlodipina e processo para sua preparação
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BR0215306A (pt) Uso de deoxipeganina
BRPI0513647A (pt) derivados de ácidos 1-fenilalcanocarboxìlicos para o tratamento de doenças neurodegenerativas
ES2177849T3 (es) Preparado farmaceutico, que contiene 2-fenil-1,2-benzoisoselenazol-3(2h)-ona, para el tratamiento de la enfermedad de alzheimer.
BR0307696A (pt) Composição desodorante ou antitranspirante
BR9714632A (pt) Preparado de combinação farmacêutica, processo para a produção de preparados de combinações farmacêuticas, utilização de preparados de eritropoietina, e de ferro, e unidade de acondicionamento farmacêutica
BR0205944A (pt) Compostos de ácido ascórbico, métodos de sìntese e suas aplicações
BR0214529A (pt) compostos terapêuticos
HUP0401234A2 (hu) Pravastatin stabil gyógyászati kompozíciója és eljárás az előállítására
BR0314811A (pt) Composto, uso do mesmo, e, intermediário de sìntese
BRPI0412554A (pt) pirazolinas como antagonistas par-1 para o tratamento de doenças distúrbios cardiovascular
UY27372A1 (es) Derivados de bencimidazol 1-aril-2-n, s u o-sustituidos, su uso para la obtención de medicamentos y preparados farmacéuticos que contienen estos derivados
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
HN2001000204A (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
BR0309684A (pt) O tratamento de dor com ifendropil

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B11E Dismissal acc. art. 34 of ipl - requirements for examination incomplete
B11T Dismissal of application maintained [chapter 11.20 patent gazette]